PT  - JOURNAL ARTICLE
AU  - Ricardo Coelho
AU  - Ana Sofia Santos
AU  - Dionísio Maia
AU  - Raquel Rosa
AU  - Vânia Caldeira
AU  - Tiago Sá
AU  - Luísa Semedo
AU  - João Cardoso
TI  - Symptoms for anxiety and depression in COPD patients
DP  - 2014 Sep 01
TA  - European Respiratory Journal
PG  - P981
VI  - 44
IP  - Suppl 58
4099  - http://erj.ersjournals.com/content/44/Suppl_58/P981.short
4100  - http://erj.ersjournals.com/content/44/Suppl_58/P981.full
SO  - Eur Respir J2014 Sep 01; 44
AB  - Background: Depression and anxiety are major contributors for the impact of COPD on patient's health status.Aim: Evaluate the relation between the symptomatic components of COPD and the presence of anxiety/depression.Methods: 100 consecutive COPD patients (pts) were assessed using the Modified Medical Research Council Dyspnea Scale (mMRC) and the COPD Assessment Test (CAT). Pts were stratified according to GOLD guidelines (using mMRC). The presence of anxiety/depression was evaluated through the Hospital Anxiety and Depression Scale.Results: The mean age was 65±9 years, 85% were male; 13 pts had spirometric stage 1, 31 had stage 2, 35 had stage 3 and 21 had stage 4; 16 pts were A, 21 were B, 14 were C and 49 were D.Thirty-one pts had anxiety and 45 had depression. Almost of all anxiety and depression pts had mMRC≥2 and CAT≥10 (29/31 and 44/45 respectively). The relation between anxiety/depression and mMRC and CAT (all sub-items) is shown in the table (for all the results p<0,05):View this table:Conclusion: The presence of anxiety and depression is associated with more severe dyspnea scores (mMRC, CAT). With CAT, others factors can be related to these comorbidities, with particular emphasis on the energy level, the ability to perform activities at home and the level of confidence to leave it.